BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 16494628)

  • 21. Building your body to survive: the use of anabolic steroids for HIV therapy.
    Vergel N
    Posit Aware; 1998; 9(2):37-41. PubMed ID: 11365225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of testosterone administration in human immunodeficiency virus-infected women with low weight: a randomized placebo-controlled study.
    Dolan S; Wilkie S; Aliabadi N; Sullivan MP; Basgoz N; Davis B; Grinspoon S
    Arch Intern Med; 2004 Apr; 164(8):897-904. PubMed ID: 15111377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus.
    Sattler FR; Jaque SV; Schroeder ET; Olson C; Dube MP; Martinez C; Briggs W; Horton R; Azen S
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1268-76. PubMed ID: 10199766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
    Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained anabolic effects of long-term androgen administration in men with AIDS wasting.
    Grinspoon S; Corcoran C; Anderson E; Hubbard J; Stanley T; Basgoz N; Klibanski A
    Clin Infect Dis; 1999 Mar; 28(3):634-6. PubMed ID: 10194091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.
    Grinspoon S; Corcoran C; Askari H; Schoenfeld D; Wolf L; Burrows B; Walsh M; Hayden D; Parlman K; Anderson E; Basgoz N; Klibanski A
    Ann Intern Med; 1998 Jul; 129(1):18-26. PubMed ID: 9652995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-dependent hepatic response to subchronic administration of nandrolone decanoate.
    Vieira RP; França RF; Damaceno-Rodrigues NR; Dolhnikoff M; Caldini EG; Carvalho CR; Ribeiro W
    Med Sci Sports Exerc; 2008 May; 40(5):842-7. PubMed ID: 18408615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate.
    Erdtsieck RJ; Pols HA; van Kuijk C; Birkenhäger-Frenkel DH; Zeelenberg J; Kooy PP; Mulder P; Birkenhäger JC
    J Bone Miner Res; 1994 Feb; 9(2):277-83. PubMed ID: 8140941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial.
    Schols AM; Soeters PB; Mostert R; Pluymers RJ; Wouters EF
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1268-74. PubMed ID: 7551381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uridine supplementation for the treatment of antiretroviral therapy-associated lipoatrophy: a randomized, double-blind, placebo-controlled trial.
    Sutinen J; Walker UA; Sevastianova K; Klinker H; Häkkinen AM; Ristola M; Yki-Järvinen H
    Antivir Ther; 2007; 12(1):97-105. PubMed ID: 17503753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of transdermal testosterone administration on insulin sensitivity, fat mass and distribution, and markers of inflammation and thrombolysis in human immunodeficiency virus-infected women with mild to moderate weight loss.
    Herbst KL; Calof OM; Hsia SH; Sinha-Hikim I; Woodhouse LJ; Buchanan TA; Bhasin S
    Fertil Steril; 2006 Jun; 85(6):1794-802. PubMed ID: 16759927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384.
    Dubé MP; Parker RA; Mulligan K; Tebas P; Robbins GK; Roubenoff R; Grinspoon SK
    Clin Infect Dis; 2007 Jul; 45(1):120-6. PubMed ID: 17554712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of androgens in patients who have HIV/AIDS: what we know about the effect of androgens on wasting and lipodystrophy.
    Abrams D
    AIDS Read; 2001 Mar; 11(3):149-56. PubMed ID: 17004352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic postmenopausal women.
    Need AG; Horowitz M; Bridges A; Morris HA; Nordin BE
    Arch Intern Med; 1989 Jan; 149(1):57-60. PubMed ID: 2912415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
    Johansen KL; Mulligan K; Schambelan M
    JAMA; 1999 Apr; 281(14):1275-81. PubMed ID: 10208142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial.
    Johansen KL; Painter PL; Sakkas GK; Gordon P; Doyle J; Shubert T
    J Am Soc Nephrol; 2006 Aug; 17(8):2307-14. PubMed ID: 16825332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer.
    Chlebowski RT; Herrold J; Ali I; Oktay E; Chlebowski JS; Ponce AT; Heber D; Block JB
    Cancer; 1986 Jul; 58(1):183-6. PubMed ID: 3518910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Approaches to the AIDS Wasting Syndrome.
    Corcoran C
    Posit Dir News; 1998; 10(2):24-7. PubMed ID: 11365549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
    Mulligan K; Zackin R; Von Roenn JH; Chesney MA; Egorin MJ; Sattler FR; Benson CA; Liu T; Umbleja T; Shriver S; Auchus RJ; Schambelan M;
    J Clin Endocrinol Metab; 2007 Feb; 92(2):563-70. PubMed ID: 17090640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.